Chymoral Forte in CKD
The provided "FDA label" information 1 appears to be for a completely different medication (likely a sleep aid/relaxant containing diphenhydramine or similar), not Chymoral Forte (trypsin-chymotrypsin enzyme preparation), making it impossible to provide evidence-based dosing guidance for the actual Chymoral Forte in CKD patients.
Critical Issue with Available Evidence
The drug label evidence provided describes a product for "occasional sleeplessness and restlessness" 1 with dosing for relaxation and sleep 1, which does not match Chymoral Forte's actual composition (proteolytic enzymes: trypsin and chymotrypsin used for inflammation and edema).
What We Know About Enzyme Preparations in CKD
Without specific pharmacokinetic data on trypsin-chymotrypsin elimination in renal impairment, and given that:
- Proteolytic enzymes are typically absorbed systemically in small amounts
- The provided guidelines 2 focus on cardiovascular and metabolic medications (RASi, SGLT2i, MRA) with no mention of enzyme preparations
- General medication safety principles in CKD 3 emphasize caution with renally eliminated drugs, but enzymes are primarily metabolized via proteolysis
Clinical Recommendation
In the absence of specific renal dosing data for actual Chymoral Forte, use with caution in CKD patients, starting at standard doses while monitoring for adverse effects, as proteolytic enzymes are not primarily renally eliminated.
Key Caveats:
- The mislabeled drug information prevents evidence-based guidance
- No major CKD guidelines address proteolytic enzyme dosing 2
- Literature on medication safety in CKD 4, 3 does not list trypsin-chymotrypsin as requiring dose adjustment
- Consider the indication carefully—anti-inflammatory enzyme therapy has limited robust evidence for efficacy
Monitoring Approach:
- Assess baseline renal function (eGFR, albuminuria)
- Watch for gastrointestinal side effects (more common than renal issues)
- Consider alternative anti-inflammatory strategies with better evidence in CKD if treating inflammation